Why Has My Weight Loss Stopped on Ozempic?
Weight loss plateaus on Ozempic are primarily caused by muscle loss reducing resting metabolic rate. Research shows up to 40% of GLP-1 weight loss is lean mass. As muscle decreases, the body burns fewer calories at rest, making continued weight loss harder even at the same dose. Protecting lean mass through creatine and protein is the most evidence-backed way to break through a plateau.
GLP-1 Resource Center
Why has my weight loss stopped on Ozempic?
Weight loss plateaus on GLP-1 medications are extremely common and have a physiological explanation that is rarely communicated to patients.
The muscle mass problem
Up to 40% of weight lost during GLP-1 treatment is lean muscle mass rather than fat. This matters for plateau prevention because muscle is the primary driver of resting metabolic rate. As muscle mass decreases, the body burns fewer calories per day at rest. The medication has not stopped working. The body has adapted to a lower metabolic baseline. This is why preventing muscle loss from the beginning of GLP-1 treatment is significantly more effective than attempting to address it after a plateau has established.
Why this is predictable
GLP-1 medications were not designed to preserve muscle mass. They reduce appetite and food intake. Without a deliberate strategy to protect lean mass through adequate protein intake and creatine, muscle loss is a predictable and progressive consequence of treatment that compounds over time.
Other contributing factors
Electrolyte and micronutrient depletion, addressed in detail on the what nutrients Ozempic depletes page, can reduce energy levels to the point where physical activity decreases. Poor sleep is associated with reduced fat burning and increased cortisol. GLP-1 fatigue and sleep disruption together create a cycle that makes maintaining the activity levels needed for continued weight loss increasingly difficult.
What the evidence supports
Protecting and rebuilding lean mass through creatine supplementation and adequate protein intake is the most evidence-backed intervention for sustaining weight loss momentum on GLP-1 medications. Adding resistance exercise two to three times per week provides the muscle-preserving stimulus that supplementation supports but cannot replace.
The TAKE approach
TAKE Build delivers 5,000mg of creatine monohydrate with electrolytes. TAKE Nourish provides 20g of plant protein per serving. Both form The Strength System.
These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement.